NervGen Pharma Corp. Common stockNGEN

$2.20+0.01 (+0.46%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$176M

Micro-cap

-50%

2025 — today

10-Year Price

-55%

2025 — today

52-Week Range

$1.73$5.97

Current $2.20· 11%

NervGen Pharma Corp. is a biotechnology enterprise currently in its clinical development phase, focused on devising therapeutic solutions for nerve injuries and progressive neurodegenerative diseases. Their innovative approach centers on deactivating the natural biological mechanisms that typically impede the nervous system's ability to repair itself.

Valuation in context

P/E ratio

-3.4

N/A

Not meaningful — company is unprofitable

P/B ratio

31.7

Below average

Below the 10-year average

FCF Yield

-15.6%

Historically low

Historically low relative to the last 10 years

Free · No credit card needed

Get alerted when NGEN is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.